 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Liza Molina, ScD, MPH1, Rodolfo R. Vega, PhD1, Thomas W Mangione, PhD2, Jacqueline J Nolan, MPH3, Aisha Moore3, and Lucille Perez, MD4. (1) JSI Research & Training Institute, Inc., 44 Farnsworth Street, Boston, MA 02210, 617.482.9485, molinald@aol.com, (2) Survey Research Group, JSI Research and Training Institute, Inc, 44 Farnsworth St, Boston, MA 02210, (3) JSI Research and Tranining Institute, 44 Farnsworth Street, Boston, MA 02210, (4) SAMHSA/CSAP, Office of Medical and Clinical Affairs, Security Lane, Rockville, MD 20852
Each year 40,000 individuals are diagnosed with HIV. As funding demands increase, implications for developing cost-effective preventive interventions are becoming highest priority. The costs to the nation related to treatment for HIV/AIDS, social services and lost productivity is staggering. In 2000, the Federal government spent approximately $8.7 billion on AIDS related costs; however, for every dollar spent on direct care, 11 cents were spent on prevention. In order for critically needed HIV/AIDS and substance abuse preventive interventions to become the standard for care in public health agencies and CBOs, cost-effectiveness must be demonstrated. A preliminary assessment on average spending in SAMSAH/CSAP-funded municipalities suggests a minimum of $330,000 (Kansas City) to over one million dollars (NYC) to sustain costs related to medical/pharmaceutical care and social services per PWA over a five-year period, exceeding spending per prevention program over a one-year period. Findings of a retrospective cost-effectiveness analysis of 47 programs participating in the SAMHSA/CSAP HIV and Substance Abuse Prevention Initiative are reported. The analysis takes into account the program costs of delivery, risk reduction behavior change impact, and factors related to econometrically modeling the number of HIV infections averted. Policy makers, community planners, and other public health decision-makers need to balance the costs and effectiveness of interventions when planning their prevention programs and making funding commitments aimed at HIV and substance abuse prevention. Well-designed economic evaluation studies are essential for providing a guide for relevant health policy and spending decisions.
Learning Objectives:
Keywords: Evaluation, Economic Analysis
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.